OU MedEd (@OUMedEd) header
OU MedEd (@OUMedEd) profile picture

Nationally-accredited #MedEd for physicians, hosting Annual Primary Care Update with OU College of Medicine connecting community docs to academia since 1997

Joined February 2014
Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)Photo by OU MedEd (@OUMedEd)
OU MedEd retweeted
#OUSOCS2022 @DrHeatherMD will open the symposium with a talk on African American Hair and Scalp Disorders #OUSkinOfColor @OUHealth #OUDermatology
2
4
OU MedEd retweeted
#OUSkinOfColor Symposium welcomes @DocTCannon Traveling the Distance: My Journey to Medicine 5/06/2022 @OUHealth
Outstanding @OUHealth Grand Rounds this morning from 🌟Dr. Marietta Ambrose on The Toolkit for the Cardiovascular Educator: Beyond COVID-19 Pandemic Among the many 🎩 she wears, Dr. Ambrose has advanced training with a Master of Science in Education from @PennMedicine
1
10
1
25
So excited for the great educational opportunity in dermatology and skin of color! #dermtwitter #MedTwitter
#OUSkinOfColor Thank you Dr. Victoria Barbosa @DrVickiBarbosa Excellent update on treatment options for hair loss in African American Women @OUHealth @DiversityOU #OUSOC
1
1
risk with diabetes. He cautioned that Omega 3’s can actually increase LDL in many cases. Interesting deep dive into how the placebo mineral oil used in REDUCE-IT may have confounded the significant reduction of CV reduction, as in the STRENGTH trial when a different mineral 2/3
3
1
oil placebo was used, there was no significant benefit; but likely the majority of that benefit can not be explained by just a harmful placebo. More clinical trial data is needed to clarify the true cv reduction benefit from icosapent ethyl 3/3 #OKACC21 @ACCinTouch @acc_oklahoma
Replying to @SanaAlkhatib9
@SanaAlkhatib9 with a stimulating talk about the utility of early AF catheter ablation in the modern era. Firstly, she highlighted that ablation is effective in reducing recurrent AF, CV hospitalization, with an impressive safety profile based on the long awaited CABANA trial 1/2
Secondly, new data highlights that an early rhythm strategy approach, and specifically ablation over AAD therapy may improve metrics such as AF recurrence, AF burden and QOL, but more data in higher risk patient populations are needed. #OKACC21 @ACCinTouch @acc_oklahoma @OUMedEd
2
1
Dr. Sana Al-Khatib @DukeHealth discusses #CABANA trial @acc_oklahoma @ACCinTouch
2
11
in the absence of left ventricular systolic dysfunction and dilation. Recognizing this entity and pursuing earlier rhythm control and/or valve repair strategies may improve outcomes in this important patient population. #OKACC21 @ACCinTouch @acc_oklahoma @OUMedEd
1
1
checkpoint inhibitors being utilized in many malignancies causing myocarditis. Guidelines and trial data are still lacking in this area and this presents an opportunity for growth and improvement in the field of cardio oncology. 2/2 #OKACC21 @ACCinTouch @acc_oklahoma @OUMedEd
2
2
Looking forward to a terrific 2021 Annual Scientific Session #okacc21 @ACCinTouch with @AnaBaracCardio @yreddyhf @SanaAlkhatib9 @dramitkhera @JGrapsa @EdwardFryMD
2
3
Tomorrow - great honour to join @ACCinTouch @ACCmediacenter @OUMedEd virtual sessions & a wonderful faculty @JACCJournals #JACCCaseReports - really grateful to Dr. Chittur Sivaram for the invitation 🌟
2
1
18
#ACCOKC2020 Dr Gary Raskob presenting on “VTE Update on Treatment and Prevention” @OUMedEd @acc_oklahoma @ACCinTouch @ACCmediacenter @ResearchOu
3
3
Coming up soon: Oklahoma ACC State of Chapter with @strehan007 @acc_oklahoma @ACCinTouch @OUMedEd
Thank you Dr. Latif for your leadership as the @acc_oklahoma Governor for the past three years! @FaisalLatifMD @ACCinTouch @oumeded
1
4
Looking forward to @GaryRaskob's presentation: Venous Thromboembolism: Update on Treatment and Prevention @acc_oklahoma @ACCinTouch @OUMedEd
1
2
#ACCOKC2020 Dr Usman Baber presenting “Antiplatelet Therapy after PCI or ACS: Contemporary Approaches and Evolving Paradigms” @acc_oklahoma @ACCinTouch @ACCmediacenter @ResearchOu @OUMedEd
1
5